methylprednisolone hemisuccinate has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furutama, D; Kimura, F; Maeda, T; Ohsawa, N; Shinoda, K; Tanaka, T | 1 |
Aishima, S; Enjoji, M; Fukui, Y; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Nakamuta, M; Takayanagi, R | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis.
Topics: Chemical and Drug Induced Liver Injury; Child; Female; Glucocorticoids; Humans; Infusions, Intravenous; Liver Function Tests; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Pulse Therapy, Drug; Treatment Outcome | 2011 |
Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Injections, Intravenous; Interferon-gamma; Lipopolysaccharides; Liver Failure, Acute; Male; Methylprednisolone Hemisuccinate; Portal Vein; Rats; Rats, Wistar; Survival Rate; Tumor Necrosis Factor-alpha | 2007 |